Back to Search
Start Over
Exploring the molecular mechanisms and therapeutic potential of SMAD4 in colorectal cancer.
- Source :
-
Cancer biology & therapy [Cancer Biol Ther] 2024 Dec 31; Vol. 25 (1), pp. 2392341. Date of Electronic Publication: 2024 Aug 20. - Publication Year :
- 2024
-
Abstract
- Colorectal Cancer (CRC) is the third most common cancer worldwide, and the occurrence and development of CRC are influenced by the molecular biology characteristics of CRC, especially alterations in key signaling pathways. The transforming growth factor-β (TGF-β) plays a crucial role in cellular growth, differentiation, migration, and apoptosis, with SMAD4 protein serving as a key transcription factor in the TGF-β signaling pathway, thus playing a significant role in the onset and progression of CRC. CRC is one of the malignancies with a high mortality rate worldwide. Despite significant research progress in recent years, especially regarding the role of SMAD4, its dual role in the early and late stages of tumor progression has promoted further discussion on its complexity as a therapeutic target, highlighting the urgent need for a deeper analysis of its role in CRC. This review aims to explore the function of SMAD4 protein in CRC and its potential as a therapeutic target.
- Subjects :
- Humans
Signal Transduction
Animals
Transforming Growth Factor beta metabolism
Gene Expression Regulation, Neoplastic
Colorectal Neoplasms metabolism
Colorectal Neoplasms pathology
Colorectal Neoplasms genetics
Colorectal Neoplasms drug therapy
Smad4 Protein metabolism
Smad4 Protein genetics
Subjects
Details
- Language :
- English
- ISSN :
- 1555-8576
- Volume :
- 25
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Cancer biology & therapy
- Publication Type :
- Academic Journal
- Accession number :
- 39164192
- Full Text :
- https://doi.org/10.1080/15384047.2024.2392341